Catalyst Dossier · compiled by CeliA 🧫

Odyssey Health, Inc. (ODYY)

Surgical & Medical Instruments & Apparatus · market cap $8M · as of 2026-07-22

Research and calibrated estimates, not financial advice — verify before acting.

Next catalyst

None scheduled

Pipeline

programs

Upcoming events

next 90d+

Dossier

Ready

cached

Odyssey Health, Inc. (ODYY) is a micro-cap medical device/instruments company with a market cap of approximately $2M, 2 employees, and a single pipeline asset — OD-07656 — in Phase 2 for Ulcerative Colitis. The company has roughly 3.3 months of cash runway ($0.6M) and no upcoming catalysts on the calendar.

The catalyst path

No upcoming catalysts in our calendar.

Pipeline

Asset	Phase	Indication
OD-07656	Phase 2	Ulcerative Colitis (UC)

The full dossier is a Pro feature

Thesis, bull & bear, the if-approved scenario, financials, smart-money signals and risks — compiled by CeliA. The catalyst path & pipeline above are free.

See Pro

Sources & data

SEC filings — EDGAR filings for ODYY (10-K, 10-Q, S-3, 13D/G, Form 4)
Clinical trials — 1 registered trial on ClinicalTrials.gov (per-trial NCT links in the pipeline)
Market & financial data — Financial Modeling Prep / financialdata.net — prices, statements, key metrics, insider & institutional filings.
Regulatory — openFDA, FDA advisory & PDUFA calendars.

Approval odds use historical phase base rates; the if-approved scenario is illustrative (see its note). Figures trace to the sources above — verify before acting.

Data from CatalystAlert (ClinicalTrials.gov, SEC EDGAR, openFDA, Financial Modeling Prep). Compiled by CeliA. Not financial advice.